Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-03

Clinical Trial Update: A PHASE II, RANDOMIZED TRIAL TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT VULVAR CANCER [Phase 2]

View source ↗

Summary

Phase II randomized trial evaluating maintenance therapy with cemiplimab versus best supportive care after first-line platinum-based chemotherapy in advanced or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cemiplimab (cemiplimab)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Vulvar Cancers | Phase 2 | Status: NOT_YET_RECRUITING